Improving Surgical/Medical Oncology Collaboration for Breast Cancer Treatment Planning: Pilot Testing the Impact of Continuing Education and Patient Care Planning
Completed · Not applicable
Conditions studied: Breast Cancer
In brief
This study will explore provider's screening and management practices for eligibility for neoadjuvant therapy from baseline to following the project intervention (use of a novel existing technology, the Carevive Care Planning System at the point of care plus provider continuing medical education.
Key facts
- Study ID
- NCT03161600
- Run by
- Carevive Systems, Inc.
- People needed
- 25
- Starts
- 2017-05-18
- Expected to finish
- 2018-12-31
- Last updated by the study team
- 2019-01-30
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- 1) 18 years of age and older
- 2) Patients must have a diagnosis of breast cancer for which they must not have received or been scheduled for primary breast surgery at time of project intervention, and must be eligible for surgical resection (i.e. Stage I-III).
You may not qualify if…
- Any patient who cannot understand written or spoken English
Where it is running
- Thomas Jefferson University Hospital — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.